GUSELKUMAB: DESCRIPTION OF CARDIOVASCULAR RISK AND EFFICACY IN PSORIASIS AND PSORIATIC ARTHRITIS IN REAL CLINICAL PRACTICE

Gilabert, A. NavarroAndujar, S. RufianGil, A. PerezPerez, C. AzabalHernandez, R.2023-05-032023-05-032022-06-010003-4967http://hdl.handle.net/10668/20058enGUSELKUMAB: DESCRIPTION OF CARDIOVASCULAR RISK AND EFFICACY IN PSORIASIS AND PSORIATIC ARTHRITIS IN REAL CLINICAL PRACTICEconference outputopen access10.1136/annrheumdis-2022-eular.8491468-2060https://ard.bmj.com/content/annrheumdis/81/Suppl_1/1564.2.full.pdf850279006278